Larvol Delta - Biodexa-to-Present-Recruitment-and-Treatment-Update-in-Phase-1-Study-of-MTX110-MAGICG1-Study-in-Patients-with-Recurrent-Glioblastoma-at-2023-Annual-European-Association-of-NeuroOncology-Meeting-EANO

panobinostat (MTX110) - Biodexa Pharma

https://www.globenewswire.com/news-release/2023/09/21/2747282/0/en/Biodexa-to-Present-Recruitment-and-Treatment-Update-in-Phase-1-Study-of-MTX-110-MAGIC-G1-Study-in-Patients-with-Recurrent-Glioblastoma-at-2023-Annual-European-Association-of-Neuro-.html

Sep 21, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next